Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS
- Conditions
- Fast-trackColon CancerParenteral Nutrition
- Interventions
- Drug: Perioperative peripheral parenteral nutrition
- Registration Number
- NCT03606863
- Lead Sponsor
- Antonio Arroyo Sebastian
- Brief Summary
Assess if administration of early nutrition support with Perioperative Peripheral Nutrition (PeriOliclimonel) N4-E) in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery (ERAS) Protocol improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy.
- Detailed Description
The main objective is to determine if perioperative nutritional support with PeriOlimel N4-E, that reaches nutritional requirements of ERAS protocol for colorectal cancer surgery patients, can improve nutritional status so it decreases postoperative complications, hospital length of stay and costs, compared to conventional fluid therapy administration since patients receive oral nutrition at day 3-5.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- scheduled colorectal cancer surgery
- ASA I-IV
- Emergency surgery
- Distant metastasis
- Patient´s refusal to participate
- Allergy or hypersensitivity to egg or soy protein
- Advanced kidney or hepatic impairment
- Severe bleeding disorders
- Congenital abnormalities of amino acid metabolism
- Hyperlipidemia and severe or difficult to control hyperglycemia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Perioperative peripheral parenteral nutrition Perioperative peripheral parenteral nutrition Perioperative peripheral parenteral nutrition during 4 days
- Primary Outcome Measures
Name Time Method morbi-mortality 30 days Early Peripheral Parenteral Nutrition in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery Protocol to improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hospital General Universitario de Elche
🇪🇸Elche, Alicante, Spain